Advertisement
Cinqair (reslizumab) has been approved by the U.S. Food and Drug Administration to treat severe asthma among adults 18 and older.

FDA Approves Cinqair for Severe Asthma

0
Lab-developed interleukin-5 antagonist monoclonal antibody helps reduce blood levels of eosinophils
Switching from prasugrel to ticagrelor is associated with a transient increase in platelet inhibition

ACC: Higher Platelet Inhibition With Switch to Ticagrelor

0
Switching from prasugrel to ticagrelor linked to transiently increased levels of platelet inhibition
Crushed prasugrel correlates with faster drug absorption for patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

ACC: Faster Absorption of Crushed Prasugrel in STEMI

0
Crushed prasugrel led to reduction in P2Y12 reaction units for up to four hours post-loading dose
More seniors than ever are taking supplements alongside their medications

Number of Seniors Mixing Medications, Supplements Rising

0
Many do not tell their doctors, putting them at risk for dangerous drug interactions
An experimental device uses a patch to monitor blood glucose levels via sweat

Sweat-Sensing Device Designed to Regulate Glucose Levels

0
Experimental technology senses blood glucose and delivers medicine with microneedles
For patients with familial adenomatous polyposis

Drug Combo Reduces Polyps in Familial Adenomatous Polyposis

0
Findings for sulindac twice daily and erlotinib daily
The U.S. Food and Drug Administration has announced that immediate-release opioid pain medications will get new boxed warnings about the dangers of misuse.

FDA Orders Enhanced Warning Labels on Opioid Pain Medications

0
New labeling rules mostly aimed at immediate-release versions of opioids
Intra-arterial chemotherapy appears to be promising for intraocular retinoblastoma

Intra-Arterial Chemo Promising for Intraocular Retinoblastoma

0
Global salvage achieved for 66 percent of all eyes across 12 single-arm cases series studies
Physicians have responded to the new U.S. Centers for Disease Control and Prevention's clinical guidelines for prescribing opioids

Physicians Respond to New CDC Opioid Guidelines

0
Mainly supportive of guidelines, but concerns include lack of evidence underlying recommendations
For patients requiring dual antiplatelet therapy

ACC: PPI Tx Also Beneficial for Those on Low-Dose Aspirin

0
Gastroprotection with PPI therapy reduced primary GI end point in patients on low-dose aspirin